Figure 2.
Prognostic impact of sPCR on disease-free survival (DFS) according to breast cancer intrinsic subtype. DFS was notably increased only in highly aggressive HR-HER2- and HER2+ tumors. (A) HR+HER2−, (B) HR+HER2+, (C) HR-HER2−, (D) HR-HER2+.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.